TO THE EDITOR
=============

Hypothyroidism is the leading cause of thyroid dysfunction and can be seen in up to 40% of these patients and appropriate treatment is critical importance \[[@ref1],[@ref2]\]. Hypothyroidism is seen most frequently in patients receiving total body irradition (TBI) containing conditioning regimens. Hypothyroidism may be seen in cases receiving chemotherapy-only conditioning regimens but less frequently \[[@ref3],[@ref4],[@ref5]\]. Here we report a case of hypoythyroidism detected 6 months after autologous hematopoietic stem cell transplantation (HSCT) for multiple myeloma (MM).

CASE REPORT
===========

A 56-year-old woman was diagnosed with Durie-Salmon stage IIIA and International Staging System stage II MM. Four cycles of VAD (Vincristine 0.4 mg for 4 days, doxorubicine 9mg/m2 for 4 days, dexamethasone 40mg for 12 days) and zoledronic acid were given. Bone marrow aspiration and biopsy was normal. Esbach was 12 g/day at the beginning and it was negative after therapy. Induction with high dose melphalan (200 mg/m2) and mobilization was performed with cyclophosphamide (4 g/m2) plus G-CSF (5-10 µg/kg/d) and HSCT was performed. Hypothyroidism was detected 6 months after transplantation. Free T3 was 0.462 pg/mL (N:T3: 2.3-4.2 pg/mL), free T4 was 0.179 ng/mL (N: 0.61-1.12 ng/mL), and TSH was 771.6 mIU/L (N: 0.34-5.6 mIU/L). She had no known prior history of thyroid dysfunction. Antimicrosomal antibody was found to be high 600.1 U/mL (normal range: less than 50) and antityroglobuline was within normal limits (2.21 mg/dL). At the beginning hypothyroidism could not be controlled and dose was increased up to 200 mcg ([Table 1](#t1){ref-type="table"}). TSH alpha subunit and hypophysis MR were performed. Pathologic finding was not found. She has been free of disease in follow-up for 3 years and with normal thyroid function.

DISCUSSION
==========

The prevalence of posttransplant hypothyroidism is highly variable and is seen in up to 58% of the cases \[[@ref1],[@ref2],[@ref3],[@ref4],[@ref5],[@ref6],[@ref7],[@ref8]\]. Niedzielska et al. reported on 16 patients after auto-HSCT and 30 patients after allo-HSCT; hypothyroidism was found in 5 of these patients (3 after allo-HSCT, 2 after auto-HSCT) in their series \[[@ref9]\]. Post-transplant hypothyroidism is seen generally after a median of 1.5 to 2 years \[[@ref3],[@ref4],[@ref9]\]. Earlier thyroid dysfunction as short as 6 months after HSCT was reported \[[@ref7]\]. The current concept of pathogenesis immune thyroiditis after allogeneic transplantation is the transfer of a clone of donor lymphocytes with antithyroidal activity. T cells play an important role in thyroid damage and also complement-mediated injury \[[@ref10]\]. Significant hypothyroidism can be seen after autologous transplantation receiving chemotherapy-only condiotioning regimen. High levels of autoimmune markers may suggest the immune etiology.
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